Coronavirus Info Center


Coronavirus (COVID-19) Information Center

We launched this section of our website in March of 2020 in order to provide you with the latest pandemic-related information and how the outbreak was impacting global shipments. Since then, we’ve been sharing breaking news, links to relevant expert sources and insights from The Quick Group’s logistics specialists. Though we had been updating this page less frequently as lockdowns and travel bans decreased with the vaccine rollout, we now find ourselves contending with a new strain of the COVID-19 variant, Omicron. We will now be publishing updates as the situation evolves on this web page, as well as on our website’s Service Alerts pages and our social media channels.

And, as always, whenever you have a question or need additional information—whether COVID-related or not—please contact your local customer service office or your Quick/Sterling representative. You can also send a question to one of our global logistics specialists via our Ask the Experts page. No matter how you’d like to connect with us, please don’t hesitate to reach out—and remember that when the unexpected happens, we are here for you.

Quick Global Priority
Sterling Aviation
Quick Specialty Logistics

The U.S. Food and Drug Administration approved today the first COVID-19 vaccine.

The U.S. Food and Drug Administration approved today the first COVID-19 vaccine.

23 Aug, 2021 - VACCINE UPDATES - North America, LATAM
It will now be marketed as Comirnaty for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine will continue being available under emergency use authorization for those 12-15 years of age and as a third dose for certain immunocompromised individuals.

Moderna says its Covid-19 vaccine is safe and appears effective in adolescents

25 May, 2021 - VACCINE UPDATES - North America
The FDA will still need to give the "green light" for this vaccine to be used in adolescents. The Moderna vaccine is already authorized for use in people ages 18 and older.

US FDA authorizes Pfizer's Covid-19 vaccine for use in people ages 12 to 15

11 May, 2021 - VACCINE UPDATES - North America
The US Food and Drug Administration has expanded the emergency use authorization for Pfizer's COVID-19 vaccine to include ages 12 - 15. This is the first COVID-19 vaccine in the US authorized for use in younger teens and adolescents.

W.H.O. approves China’s Sinopharm vaccine for emergency use.

The World Health Organization approved China's Sinopharm COVID-19 vaccine for emergency use, easing the way for poorer nations to have access to the shot to help end the pandemic

Canada authorizes coronavirus vaccine for children ages 12 to 15

05 May, 2021 - VACCINE UPDATES - North America
Canada has authorized the use of the Pfizer/BioNTech vaccine for children between the ages of 12 and 15. Canada is the first country in the world to do so.
Also today: The US FDA is expected to authorize the use of this vaccine for 12- to 15-year-olds very soon.

Vaccine news: Pfizer announced today the results of a study, which shows their COVID-19 vaccine is 90% effective for at least 6 months—and protects against the South Africa variant.

01 Apr, 2021 - VACCINE UPDATES -
This comes after yesterday's announcement that their coronavirus vaccine was 100% effective in preventing COVID-19 in children ages 12 to 15.